These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 33195532)

  • 1. Efficacy and Safety of Intramuscular Insulin Lispro vs. Continuous Intravenous Regular Insulin for the Treatment of Dogs With Diabetic Ketoacidosis.
    Malerba E; Alessandrini F; Grossi G; Giunti M; Fracassi F
    Front Vet Sci; 2020; 7():559008. PubMed ID: 33195532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Use of lispro insulin for treatment of diabetic ketoacidosis in dogs.
    Sears KW; Drobatz KJ; Hess RS
    J Vet Emerg Crit Care (San Antonio); 2012 Apr; 22(2):211-8. PubMed ID: 22390184
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Use of intravenous insulin aspart for treatment of naturally occurring diabetic ketoacidosis in dogs.
    Walsh ES; Drobatz KJ; Hess RS
    J Vet Emerg Crit Care (San Antonio); 2016; 26(1):101-7. PubMed ID: 26379102
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy of subcutaneous insulin lispro versus continuous intravenous regular insulin for the treatment of patients with diabetic ketoacidosis.
    Umpierrez GE; Latif K; Stoever J; Cuervo R; Park L; Freire AX; E Kitabchi A
    Am J Med; 2004 Sep; 117(5):291-6. PubMed ID: 15336577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Use of lispro insulin for treatment of diabetic ketoacidosis in cats.
    Malerba E; Mazzarino M; Del Baldo F; Corradini S; Carotenuto G; Giunti M; Fracassi F
    J Feline Med Surg; 2019 Feb; 21(2):115-123. PubMed ID: 29513157
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Treatment of diabetic ketoacidosis with subcutaneous insulin lispro: a review of the current evidence from clinical studies.
    Vincent M; Nobécourt E
    Diabetes Metab; 2013 Sep; 39(4):299-305. PubMed ID: 23642642
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Subcutaneous use of a fast-acting insulin analog: an alternative treatment for pediatric patients with diabetic ketoacidosis.
    Della Manna T; Steinmetz L; Campos PR; Farhat SC; Schvartsman C; Kuperman H; Setian N; Damiani D
    Diabetes Care; 2005 Aug; 28(8):1856-61. PubMed ID: 16043723
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lispro insulin and electrolyte supplementation for treatment of diabetic ketoacidosis in cats.
    Anderson JD; Rondeau DA; Hess RS
    J Vet Intern Med; 2019 Jul; 33(4):1593-1601. PubMed ID: 31134702
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot study comparing a protocol using intermittent administration of glargine and regular insulin to a continuous rate infusion of regular insulin in cats with naturally occurring diabetic ketoacidosis.
    Gallagher BR; Mahony OM; Rozanski EA; Buob S; Freeman LM
    J Vet Emerg Crit Care (San Antonio); 2015; 25(2):234-9. PubMed ID: 25546713
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Efficacy and Safety of Commonly Used Insulin Analogues in the Treatment of Diabetic Ketoacidosis: A Bayesian Indirect Treatment Comparison.
    Vidyasagar K; Chandrasekar B; Chhabra M; Bhansali A; Bansal D
    Clin Ther; 2020 Aug; 42(8):e115-e139. PubMed ID: 32798057
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retrospective comparison of early- versus late-insulin therapy regarding effect on time to resolution of diabetic ketosis and ketoacidosis in dogs and cats: 60 cases (2003-2013).
    DiFazio J; Fletcher DJ
    J Vet Emerg Crit Care (San Antonio); 2016; 26(1):108-15. PubMed ID: 26551019
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Subcutaneous lispro and intravenous regular insulin treatments are equally effective and safe for the treatment of mild and moderate diabetic ketoacidosis in adult patients.
    Ersöz HO; Ukinc K; Köse M; Erem C; Gunduz A; Hacihasanoglu AB; Karti SS
    Int J Clin Pract; 2006 Apr; 60(4):429-33. PubMed ID: 16620355
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Management of diabetic ketosis and ketoacidosis with intramuscular regular insulin in a low-resource family medicine setting.
    Basetty S; Yeshvanth Kumar GS; Shalini M; Angeline RP; David KV; Abraham S
    J Family Med Prim Care; 2017; 6(1):25-28. PubMed ID: 29026743
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comparison of insulin infusion protocols for management of canine and feline diabetic ketoacidosis.
    Gant P; Barfield D; Florey J
    J Vet Emerg Crit Care (San Antonio); 2024; 34(1):23-30. PubMed ID: 37987148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of diabetic ketoacidosis with subcutaneous insulin aspart.
    Umpierrez GE; Cuervo R; Karabell A; Latif K; Freire AX; Kitabchi AE
    Diabetes Care; 2004 Aug; 27(8):1873-8. PubMed ID: 15277410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glargine versus regular insulin protocol in feline diabetic ketoacidosis.
    Zeugswetter FK; Luckschander-Zeller N; Karlovits S; Rand JS
    J Vet Emerg Crit Care (San Antonio); 2021 Jul; 31(4):459-468. PubMed ID: 33945208
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of Bolus Insulin Administration Followed by a Continuous Insulin Infusion on Diabetic Ketoacidosis Management.
    Brown HD; Tran RH; Patka JH
    Pharmacy (Basel); 2018 Dec; 6(4):. PubMed ID: 30544554
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of subcutaneous insulin aspart and intravenous regular insulin for the treatment of mild and moderate diabetic ketoacidosis in pediatric patients.
    Razavi Z; Maher S; Fredmal J
    Endocrine; 2018 Aug; 61(2):267-274. PubMed ID: 29797212
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Managing diabetic ketoacidosis in non-intensive care unit setting: Role of insulin analogs.
    Karoli R; Fatima J; Salman T; Sandhu S; Shankar R
    Indian J Pharmacol; 2011 Jul; 43(4):398-401. PubMed ID: 21844993
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Efficacy and safety of two protocols of intravenous insulin therapy in the management of diabetic ketoacidosis.
    Jouini S; Othmani S; Aloui A; Bouzid K; Manai H; Hedhli H
    Tunis Med; 2022 Decembre; 100(12):830-836. PubMed ID: 37551533
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.